Recent events

Every US listed company has to file a Form 8-K within four business days of something significant happening, and tag it with the item number that says what kind of thing it was. This is that feed, over the last 180 days - the filings themselves, on EDGAR, one click away. Nothing here is a summary of what a filing said; it is what the company told SEC it was filing about.

Every 8-K item filed, including the routine ones - earnings dates, shareholder votes and Regulation FD disclosures. Not the exhibit lists.

Date Company Event Filing
Aura Biosciences, Inc. AURA Officer or director change Item 5.02 Form 8-K
Aura Biosciences, Inc. AURA Other event Item 8.01 Form 8-K
Autolus Therapeutics plc AUTL Results announced Item 2.02 Form 8-K
Autolus Therapeutics plc AUTL Regulation FD disclosure Item 7.01 Form 8-K
Avidbank Holdings, Inc. AVBH Regulation FD disclosure Item 7.01 Form 8-K
Azenta, Inc. AZTA Officer or director change Item 5.02 Form 8-K
B&G Foods, Inc. BGS Results announced Item 2.02 Form 8-K
B&G Foods, Inc. BGS Officer or director change Item 5.02 Form 8-K
B&G Foods, Inc. BGS Regulation FD disclosure Item 7.01 Form 8-K
B&G Foods, Inc. BGS Regulation FD disclosure Item 7.01 Form 8-K
BERKSHIRE HATHAWAY INC BRK-B Results announced Item 2.02 Form 8-K
BEYOND MEAT, INC. BYND Other event Item 8.01 Form 8-K
BIG SKY INDUSTRIAL INC. BSIN Results announced Item 2.02 Form 8-K
BOSTON BEER CO INC SAM Other event Item 8.01 Form 8-K
BROADWIND, INC. BWEN Results announced Item 2.02 Form 8-K
BROADWIND, INC. BWEN Regulation FD disclosure Item 7.01 Form 8-K
Beneficient BENF New debt or obligation Item 2.03 Form 8-K
Bicara Therapeutics Inc. BCAX Results announced Item 2.02 Form 8-K
BioXcel Therapeutics, Inc. BTAI Material agreement signed Item 1.01 Form 8-K
BiomX Inc. PHGE Material agreement signed Item 1.01 Form 8-K
BiomX Inc. PHGE Unregistered share sale Item 3.02 Form 8-K
Black Rock Coffee Bar, Inc. BRCB Results announced Item 2.02 Form 8-K
Blend Labs, Inc. BLND Officer or director change Item 5.02 Form 8-K
Bluerock Homes Trust, Inc. BHM Acquisition or disposal completed Item 2.01 Form 8-K
Bolt Biotherapeutics, Inc. BOLT Results announced Item 2.02 Form 8-K
Boxlight Corp BOXL Material agreement signed Item 1.01 Form 8-K
Boxlight Corp BOXL Unregistered share sale Item 3.02 Form 8-K
Boxlight Corp BOXL Charter or fiscal year changed Item 5.03 Form 8-K
Boxlight Corp BOXL Other event Item 8.01 Form 8-K
BridgeBio Oncology Therapeutics, Inc. BBOT Results announced Item 2.02 Form 8-K
Burke & Herbert Financial Services Corp. BHRB Officer or director change Item 5.02 Form 8-K
Butterfly Network, Inc. BFLY Officer or director change Item 5.02 Form 8-K
C4 Therapeutics, Inc. CCCC Results announced Item 2.02 Form 8-K
CARDINAL HEALTH INC CAH Annual report filed FY to 2026-06-30 Form 10-K
CARDINAL HEALTH INC CAH Material agreement signed Item 1.01 Form 8-K
CARDINAL HEALTH INC CAH Material agreement terminated Item 1.02 Form 8-K
CARDINAL HEALTH INC CAH Results announced Item 2.02 Form 8-K
CARDINAL HEALTH INC CAH New debt or obligation Item 2.03 Form 8-K
CARDINAL HEALTH INC CAH Regulation FD disclosure Item 7.01 Form 8-K
CAVA GROUP, INC. CAVA Results announced Item 2.02 Form 8-K

Item numbers are Form 8-K's own. An 8-K says that a company filed about something, not what it decided - a management change under item 5.02 covers both a routine board retirement and a chief executive being removed, and only the filing tells you which. Dates are filing dates: an 8-K is due within four business days of the event, so the event itself is up to a week earlier. Events are collected from each company's SEC submissions index, which reaches back roughly a thousand filings - for a company that files often, that is less than three years.